/ Sign-up


Latest Posts


We are targeting a range of vaccines addressing both the pediatric market and the adult vaccines market, including the current products included in the Extended Program of Immunization (EPI) of the targeted countries, as well as vaccines already used in mature markets and not yet adopted for public use in our targeted countries, and lastly innovative vaccines addressing unmet epidemiological and medical needs indigenous to these countries.

AJ Biologics is committed to developing newer and more effective vaccines through ongoing research.